NCT00826501

Brief Summary

Patients with pancreatitis can develop inflammatory fluid collection around the pancreas called pseudocysts. Pseudocysts may cause abdominal pain when they are more than 6cm in size. These pseudocysts can be treated (drained) by surgery or by endoscopy. Both treatment options are the current standard-of-care at all institutions around the World. The aim of this study is to identify the better of the two techniques, surgery versus endoscopy, for treatment of patients with pancreatic pseudocysts. This will be done by comparing a) the rates of pseudocyst recurrence b) quality of life of patients following treatment and c) cost associated with treatment, between both treatment modalities.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2009

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2009

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

January 20, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 22, 2009

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2009

Completed
2.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2012

Completed
Last Updated

March 18, 2013

Status Verified

March 1, 2013

Enrollment Period

11 months

First QC Date

January 20, 2009

Last Update Submit

March 15, 2013

Conditions

Outcome Measures

Primary Outcomes (1)

  • Compare median time to pseudocyst recurrence between patients undergoing EUS or Surgical Cysto-gastrostomy

    24 months

Secondary Outcomes (2)

  • Quality of Life following treatment which will be assessed on a 3-month basis for 24-months using the SF-36 questionnaire

    24 months

  • Median time to pseudocyst recurrence at 24 month follow-up.

    24 months

Other Outcomes (1)

  • Compare pain medication usage

    24 months

Study Arms (2)

1

ACTIVE COMPARATOR

Endoscopic cyst-gastrostomy with a neurolytic block along with oral/transdermal analgesic therapy

Procedure: Endoscopic cyst-gastrostomy

2

ACTIVE COMPARATOR

Surgical cyst-gastrostomy with neurolytic block and pain managed by only oral/transdermal analgesic

Procedure: Surgical cyst-gastrostomy

Interventions

After passing a small camera into the stomach the pseudocyst will be punctured and drained into the stomach by stent placement.

1

After making an incision in the abdomen the pseudocyst contents will be emptied and the pseudocyst will be sutured to the stomach.

2

Eligibility Criteria

Age19 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age \> 19yrs
  • able to provide informed consent
  • pancreatic pseudocyst by CT

You may not qualify if:

  • age \< 19yrs
  • unable to consent
  • pancreatic abscess or necrosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alabama at birmingham

Birmingham, Alabama, 35244, United States

Location

Related Publications (1)

  • Varadarajulu S, Bang JY, Sutton BS, Trevino JM, Christein JD, Wilcox CM. Equal efficacy of endoscopic and surgical cystogastrostomy for pancreatic pseudocyst drainage in a randomized trial. Gastroenterology. 2013 Sep;145(3):583-90.e1. doi: 10.1053/j.gastro.2013.05.046. Epub 2013 May 31.

MeSH Terms

Conditions

Pancreatic Pseudocyst

Condition Hierarchy (Ancestors)

Pancreatic CystCystsNeoplasmsPancreatic DiseasesDigestive System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 20, 2009

First Posted

January 22, 2009

Study Start

January 1, 2009

Primary Completion

December 1, 2009

Study Completion

January 1, 2012

Last Updated

March 18, 2013

Record last verified: 2013-03

Locations